SELLAS Announces Positive Follow-Up Phase 1/2 Clinical Data for Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML)

    NEXT STORY
    Novavax Advances Development of Novel COVID-19 Vaccine
    PREV STORY
    CHF Solutions receives 510(k) clearance for Aquadex SmartFlow™ system in Pediatric Patients Weighing 20kg or More
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    RedHill Biopharma Reports Third Quarter 2018 Financial Results and Business Highlights

    Key Highlights: Top-line results from the confirmatory Phase III study with TALICIA® for H. ...

    author_avatar
    NASDAQ Market News

    Celsion to Present Two Posters on its GEN-1 IL-12 Gene-Mediated Immunotherapy at the ASCO-SITC Clinical Immuno-Oncology Symposium

    LAWRENCEVILLE, N.J., Jan. 19, 2017 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ:CLSN) today announced that it ...

    author_avatar
    NASDAQ Market News

    Genesis HealthCare Reports Fourth Quarter and Fiscal Year End 2017 Results

    author_avatar
    NASDAQ Market News